Singapore firm comes up with world’s first molecular blood test for early detection of gastric cancer


Associate Professor Too Heng-Phon, co-founder of Mirxes, which developed the test kit for early detection of gastric cancer. - The Straits Times/ANN

SINGAPORE, Nov 27 (The Straits Times/ANN): When Associate Professor Too Heng-Phon was about to start biotech firm Mirxes back in 2010, he asked several of his PhD students to join him, but also warned them that it would be tough going.

Two of them decided to help set up the home-grown biotechnology firm, which went on to develop test kits that use blood-based microRNAs (miRNAs) to serve as biomarkers for early detection of cancers.

Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Singapore , Gastric Cancer , Research

Next In Aseanplus News

France detains two more suspects over foiled Paris Bank of America attack
Residents affected by Hong Kong fire at Tai Po district get window for retrieval of their belongings
Chief Justice of Malaysia, IGP lead honours list for Sabah Governor's 75th birthday
Asean News Headlines at 10pm on Sunday (March 29, 2026)
World in turmoil - the Mideast War: Iran accuses US of plotting ground attack despite diplomatic talk
Indonesia eyes US$2.3 billion savings from cut in free meal distribution due to Mideast war turmoil
Thailand launches cost-of-living schemes amid rising prices due to Middle East war
Thorny talks on agriculture, fishing at WTO meet; current global issues are not helping either
Cheras landlord allegedly attacked by tenant in tiff over parking
Rain in parts of Kedah brings relief after prolonged hot spell

Others Also Read